Purpose: To assess the cytotoxicity and genotoxicity of intravitreal adalimumab treatment in an animal experimental model using cytological and molecular techniques. Methods: Eighteen rabbits were randomly assigned to three groups: control, adalimumab treatment, and placebo. Cytotoxicity on retinal cells was evaluated using flow cytometry assays to determine the level of apoptosis and necrosis. Genotoxicity was evaluated by comet assays to assess DNA damage, and quantitative real-time polymerase chain reaction (qPCR) was used to evaluate expression of apoptosis-inducing caspases (8 and 3). Results: No cytotoxicity or genotoxicity was observed in any of the two treatment groups (adalimumab and placebo) following intravitreal administration c...
Purpose: The cytotoxicity of single and repeated administration of bevacizumab to retinal ganglion c...
WOS: 000347391500008PubMed ID: 25285465Purpose: The purpose of this experiment was to investigate th...
13 p.-5 fig.-1 tab. Cristina Martínez-Fernández de la Cámara et alt.Growing evidence suggests that i...
Purpose: To assess the cytotoxicity and genotoxicity of intravitreal adalimumab treatment in an ani...
Purpose: To evaluate the ocular toxicity of escalating doses of intravitreous adalimumab (Humira (R)...
Purpose To evaluate the ocular toxicity of escalating doses of intravitreous adalimumab (Humira) in ...
O adalimumabe (Humira®, Abbott) é um antagonista do Fator de Necrose Tumoral- alpha (TNF-alfa ). É a...
Aim: To study the effects of the tumor necrosis factor alpha inhibitor adalimumab on rabbit retina a...
Purpose: The purpose of this prospective experimental study was to evaluate the safety/toxicity of α...
Background/aim: To investigate the effect of intravitreal golimumab on rabbit retina histopathology
Purpose: To analyze the retinal effects of the intravitreally administered vascular endothelial grow...
Background: Tumor necrosis factor (TNF) is known to play an important role in various immune-mediate...
OBJECTIVE: Bevacizumab has been widely used as a vascular endothelial growth factor antagonist in th...
PubMed ID: 25285465Purpose: The purpose of this experiment was to investigate the possible toxic eff...
The adverse effects of drugs in the eye are not easily detected, and the underlying pathogenesis not...
Purpose: The cytotoxicity of single and repeated administration of bevacizumab to retinal ganglion c...
WOS: 000347391500008PubMed ID: 25285465Purpose: The purpose of this experiment was to investigate th...
13 p.-5 fig.-1 tab. Cristina Martínez-Fernández de la Cámara et alt.Growing evidence suggests that i...
Purpose: To assess the cytotoxicity and genotoxicity of intravitreal adalimumab treatment in an ani...
Purpose: To evaluate the ocular toxicity of escalating doses of intravitreous adalimumab (Humira (R)...
Purpose To evaluate the ocular toxicity of escalating doses of intravitreous adalimumab (Humira) in ...
O adalimumabe (Humira®, Abbott) é um antagonista do Fator de Necrose Tumoral- alpha (TNF-alfa ). É a...
Aim: To study the effects of the tumor necrosis factor alpha inhibitor adalimumab on rabbit retina a...
Purpose: The purpose of this prospective experimental study was to evaluate the safety/toxicity of α...
Background/aim: To investigate the effect of intravitreal golimumab on rabbit retina histopathology
Purpose: To analyze the retinal effects of the intravitreally administered vascular endothelial grow...
Background: Tumor necrosis factor (TNF) is known to play an important role in various immune-mediate...
OBJECTIVE: Bevacizumab has been widely used as a vascular endothelial growth factor antagonist in th...
PubMed ID: 25285465Purpose: The purpose of this experiment was to investigate the possible toxic eff...
The adverse effects of drugs in the eye are not easily detected, and the underlying pathogenesis not...
Purpose: The cytotoxicity of single and repeated administration of bevacizumab to retinal ganglion c...
WOS: 000347391500008PubMed ID: 25285465Purpose: The purpose of this experiment was to investigate th...
13 p.-5 fig.-1 tab. Cristina Martínez-Fernández de la Cámara et alt.Growing evidence suggests that i...